Status:
COMPLETED
Human Chorionic Gonadotropin (hCG) Priming Prior to Controlled Ovarian Hyperstimulation (COH) in Poor Responder In Vitro Fertilization (IVF) Patients
Lead Sponsor:
IVI Madrid
Conditions:
Ovarian Response
Eligibility:
FEMALE
18-41 years
Phase:
PHASE4
Brief Summary
There is a decline in androgen concentration with ovarian aging. Also, ovarian response to COH in IVF cycles diminishes with ovarian aging. Recent evidence suggest that testosterone or DHEA may improv...
Eligibility Criteria
Inclusion
- previous IVF cycle with 5 or less mature follicles or 5 or less oocyte retrieved
Exclusion
- 42 years or older
- BMI \<18 or \>30
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00870025
Start Date
October 1 2008
End Date
September 1 2010
Last Update
April 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI-Madrid
Madrid, Spain, 28023